首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Signal transduction and targeted therapy

缩写:

ISSN:2095-9907

e-ISSN:2059-3635

IF/分区:52.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2606
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zhan-Li Chen,Chen Xie,Wei Zeng et al. Zhan-Li Chen et al.
Mitotic catastrophe (MC), which occurs under dysregulated mitosis, represents a fascinating tactic to specifically eradicate tumor cells. Whether pyroptosis can be a death form of MC remains unknown. Proteasome-mediated protein degradation ...
Xixi Guo,Xiaosa Zhao,Xi Lu et al. Xixi Guo et al.
Helicobacter pylori (H. pylori) is currently recognized as the primary carcinogenic pathogen associated with gastric tumorigenesis, and its high prevalence and resistance make it difficult to tackle. A graph neural network-based deep learni...
Xianjing Chu,Wentao Tian,Jiaoyang Ning et al. Xianjing Chu et al.
Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor heterogeneity. Cancer continues to be a significant globa...
Hao Peng,Meng Yang,Kun Feng et al. Hao Peng et al.
More than 90% of hepatocellular carcinoma (HCC) cases develop in the presence of fibrosis or cirrhosis, making the tumor microenvironment (TME) of HCC distinctive due to the intricate interplay between cancer-associated fibroblasts (CAFs) a...
Peilin Lu,Dongxue Ruan,Meiqi Huang et al. Peilin Lu et al.
The applications of hydrogels have expanded significantly due to their versatile, highly tunable properties and breakthroughs in biomaterial technologies. In this review, we cover the major achievements and the potential of hydrogels in the...
Yanni Wang,Chang Liu,Huan Chen et al. Yanni Wang et al.
Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. Our preclinical data showed the promising antitumor ac...